Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events

Author:

Cates Christopher J1,Jaeschke Roman2,Schmidt Stefanie3,Ferrer Montse3

Affiliation:

1. St George's, University of London; Population Health Sciences and Education; Cranmer Terrace London UK SW17 0RE

2. McMaster University; Department of Medicine and Department of Clinical Epidemiology and Biostatistics; 301 James Street South Hamilton, Ontario Canada L8P3B6

3. IMIM (Hospital del Mar Medical Research Institute); Health Services Research Unit; Doctor Aiguader 88 Barcelona Spain 08003

Publisher

Wiley

Subject

Pharmacology (medical)

Reference252 articles.

1. SFCB3019 http://ctr.gsk.co.uk/Summary/fluticasone_salmeterol/III_SFCB3019.pdf Accessed July 2008

2. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma;Aubier;Respiratory Medicine,1999

3. A Multicenter, Randomized, Double-Blind, Parallel Group, 52-Week Comparison of Asthma Control and Measures of Airway Inflammation in Subjects of African Descent Receiving Fluticasone Propionate/Salmeterol100/50mcg DISKUS™ BID or Fluticasone Propionate 100mcg DISKUS™ BID Alone http://www.gsk-clinicalstudyregister.com Accessed September 2012

4. Bailey W Castro M Matz J White M Dransfield M Yancey S Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone Current Medical Research and Opinion 2008 1669 82

5. SFCB3022 http://ctr.gsk.co.uk/Summary/fluticasone_salmeterol/III_SFCB3022.pdf Accessed July 2008

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3